BluePen Biomarkers LLC: integrated biomarker solutions
نویسندگان
چکیده
منابع مشابه
BluePen Biomarkers LLC: integrated biomarker solutions
BluePen Biomarkers provides a unique comprehensive multi-omics biomarker discovery and validation platform. We can quantify, integrate and analyze genomics, proteomics, metabolomics and lipidomics biomarkers, alongside clinical data, demographics and other phenotypic data. A unique bio-inspired signal processing analytic approach is used that has the proven ability to identify biomarkers in a w...
متن کاملImaging Biomarkers or Biomarker Imaging?
Since biomarker imaging is traditionally understood as imaging of molecular probes, we highly recommend to avoid any confusion with the previously defined term "imaging biomarkers" and, therefore, only use "molecular probe imaging (MPI)" in that context. Molecular probes (MPs) comprise all kinds of molecules administered to an organism which inherently carry a signalling moiety. This review hig...
متن کاملIntegrated Electronic Solutions
APPLIED CLINICAL TRIALS February 2002 or years, the pharmaceutical industry has recognized the inefficiencies of the clinical trial process. Paperless processes, standards, and real-time acquisition and access to data have long been the “Holy Grail” of the industry. The explosion of information technology has created tremendous possibilities for streamlining the clinical development process. Fo...
متن کاملIntegrated Palletizing Solutions
Since 1976, PASCO has designed and manufactured custom palletizing systems. Our deep understanding and hands-on experience in conventional palletizers has provided us a solid foundation to quickly become a leading robotic palletizing integrator for Fanuc Robotics NA. If there are bags, bales, bundles, cases, drums, pails and/or trays to be palletized, PASCO has the engineering expertise and pra...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Future Science OA
سال: 2016
ISSN: 2056-5623
DOI: 10.4155/fsoa-2016-0031